What is Charles River Laboratories International's stock symbol?
What is Charles River Laboratories International's stock symbol? Charles River Laboratories International trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRL." Who are Charles River Laboratories International's major shareholders?
Where can I buy CRL shares?
Shares of CRL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
What is Charles River Laboratories International's PE (CHR) ratio?
The P/E ratio of Charles River Laboratories International is 45.87, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.23.
Is CRL a good Stock to buy?
Out of 10 analysts, 8 (80%) are recommending CRL as a Strong Buy, 0 (0%) are recommending CRL as a Buy, 2 (20%) are recommending CRL as a Hold, 0 (0%) are recommending CRL as a Sell, and 0 (0%) are recommending CRL as a Strong Sell.
What does CRL stand for in Stocks?
CRL Stock Abbreviation1CRLTicker Symbols, River, Laboratory1CRLRiver, Laboratory, Supply
Should I buy or sell Charles River Laboratories International stock right now?
14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Charles River Laboratories International in the last tw...
What is Charles River Laboratories International's stock price forecast for 2022?
14 analysts have issued twelve-month price objectives for Charles River Laboratories International's stock. Their CRL stock forecasts range from $2...
How has Charles River Laboratories International's stock price performed in 2022?
Charles River Laboratories International's stock was trading at $376.78 at the beginning of 2022. Since then, CRL shares have decreased by 41.7% an...
When is Charles River Laboratories International's next earnings date?
Charles River Laboratories International is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022. View our...
How were Charles River Laboratories International's earnings last quarter?
Charles River Laboratories International, Inc. (NYSE:CRL) issued its earnings results on Wednesday, May, 4th. The medical research company reported...
What guidance has Charles River Laboratories International issued on next quarter's earnings?
Charles River Laboratories International issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per s...
Who are Charles River Laboratories International's key executives?
Charles River Laboratories International's management team includes the following people: Mr. James C. Foster J.D. , Chairman, CEO & Pres (Age 7...
What is James C. Foster's approval rating as Charles River Laboratories International's CEO?
291 employees have rated Charles River Laboratories International CEO James C. Foster on Glassdoor.com . James C. Foster has an approval rating of...
Who are some of Charles River Laboratories International's key competitors?
Some companies that are related to Charles River Laboratories International include Thermo Fisher Scientific (TMO) , Agilent Technologies (A) ,...
Is Charles River Laboratories International stock a Buy, Sell or Hold?
Charles River Laboratories International stock has received a consensus rating of buy. The average rating score is and is based on 19 buy ratings,...
What was the 52-week low for Charles River Laboratories International stock?
The low in the last 52 weeks of Charles River Laboratories International stock was 214.77. According to the current price, Charles River Laboratori...
What was the 52-week high for Charles River Laboratories International stock?
The high in the last 52 weeks of Charles River Laboratories International stock was 460.21. According to the current price, Charles River Laborator...
What are analysts forecasts for Charles River Laboratories International stock?
The 23 analysts offering price forecasts for Charles River Laboratories International have a median target of 327.74, with a high estimate of 465.0...
What is Charles River Laboratories?
How much does Charles River make?
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains and purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets and chemical compounds through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company was founded in 1947 and is based in Wilmington, Massachusetts.
New York Stock Exchange
Charles River Laboratories International has a market capitalization of $19.74 billion and generates $2.92 billion in revenue each year. The medical research company earns $364.30 million in net income (profit) each year or $8.13 on an earnings per share basis.
Environmental, Social, and Governance Rating
Charles River supports early-stage drug development with a “research models” business that breeds lab rats and “preclinical services” that run clinical trials for pharma and biotech companies.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
0.0 Analyst's Opinion
Charles River supports early-stage drug development with a “research models” business that breeds lab rats and “preclinical services” that run clinical trials for pharma and biotech companies.
Who are some of Charles River Laboratories International's key competitors?
There is not enough analysis data for Charles River Laboratories International.
What is Charles River Laboratories International's stock symbol?
Some companies that are related to Charles River Laboratories International include Australian Clinical Labs (ACL), BARD1 Life Sciences (BD1), Biomark Diagnostics (BUX), Cryosite (CTE), dorsaVi (DVL), Epigenomics (EPGNY), Eternity Healthcare (ETAH), Genetic Signatures (GSS), Genetic Technologies (GTG), Imagin Medical (IME), Imagion Biosystems (IBX), Integral Diagnostics (IDX), Lifespot Health (LSH), Med BioGene (MBGNF) and Medical Imaging (MEDD). View all of CRL's competitors..
How do I buy shares of Charles River Laboratories International?
Charles River Laboratories International trades on the CNSX under the ticker symbol "CRL."
How many employees does Charles River Laboratories International have?
Shares of CRL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What is Charles River Laboratories International's official website?
Charles River Laboratories International employs 18,400 workers across the globe.
Where are Charles River Laboratories International's headquarters?
The official website for Charles River Laboratories International is carlsolutions.com.
Component Grades
Charles River Laboratories International is headquartered at 891 Cambie St, VANCOUVER, BC V6B 2P4, Canada.
CRL POWR Grades
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
CRL Valuation Summary
CRL scores best on the Sentiment dimension, with a Sentiment rank ahead of 83.97% of US stocks.
CRL's Quality Factors
CRL's price/sales ratio is 6.8; this is 40.09% lower than that of the median Healthcare stock.
Latest CRL News From Around the Web
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
Continue Researching CRL
Below are the latest news stories about Charles River Laboratories International Inc that investors may wish to consider to help them evaluate CRL as an investment opportunity.